Managing post-bariatric weight recurrence with new obesity management medications

Davide Masi, Francesco De Domenico, Valeria Zanghi Buffi, Rossella Tozzi, Valentina Cipriani, Ludovico Di Gioia, Sergio Di Molfetta, Irene Caruso, Fiammetta Cipriani, Maurizio De Luca, Lidia Castagneto-Gissey, Sebastio Perrini, Daniele Gianfrilli, Andrea Marcello Isidori, Francesco Giorgino, Geltrude Mingrone, Carel W. le Roux, Silvia Manfrini, Karine Clément, Mikiko Watanabe, Dario Tuccinardi
Nature Reviews Endocrinology · Springer Nature · 2026-11-19 · DOI: 10.1038/s41574-026-01324-y

Abstract

Nature Reviews Endocrinology, Published online: 19 November 2026; doi:10.1038/s41574-026-01324-y In this Review, the authors discuss the factors that contribute to recurrent weight gain after metabolic and bariatric surgery, treatment of this weight gain, and the available evidence for the role of anti-obesity medications in managing this condition. The Review also covers insufficient weight loss and suboptimal clinical response after metabolic and bariatric surgery.

Read at publisher →

Similar articles